Clinical trial
A Prospective, Open-Label Study to Evaluate Subject's Satisfaction With the Aesthetics of the Periorbital Area After Treatment of the Upper and/or Mid Face With JUVÉDERM® Fillers and BOTOX®/VISTABEL®
NCT05647551 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open-Label Study to Evaluate Subject's Satisfaction With the Aesthetics of the Periorbital Area After Treatment of the Upper and/or Mid Face With JUVÉDERM® Fillers and BOTOX®/VISTABEL®
- Lead sponsor
- AbbVie
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 5, 2023
- Completion date
- October 5, 2023
- Enrollment
- 73 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
facial corrections, facial lines